GlassScriptPhysician profile
Jerimiah Capen Johnson
NPI 1770998429
$12,097.40
in general payments reported to CMS, 2019-2025
47 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,621 · 2020: $1,941 · 2021: $2,490 · 2022: $1,831 · 2023: $1,277 · 2024: $1,327 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,214.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,485.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,346.50 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,170.91 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,075.07 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $988.13 | 2019-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $908.76 | 2019-2022 | |
| Lilly USA, LLC | $703.69 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $576.80 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $415.27 | 2019-2024 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $363.16 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $342.20 | 2020-2023 | Trintellix |
| Abbott Laboratories | $303.38 | 2023-2025 | Freestyle Libre 3, Xience Skypoint, Optis |
| Novartis Pharmaceuticals Corporation | $258.69 | 2019-2025 | |
| Amarin Pharma, INC. | $222.65 | 2019-2022 | |
| Astellas Pharma US INC | $212.33 | 2019-2023 | Myrbetriq |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerimiah Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.